Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Treasury Shares: 2020-2024

Historic Treasury Shares for Mereo BioPharma Group (MREO) over the last 4 years, with Dec 2023 value amounting to $1.2 million.

  • Mereo BioPharma Group's Treasury Shares fell 7.87% to $1.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.2 million, marking a year-over-year decrease of 7.87%. This contributed to the annual value of $1.2 million for FY2023, which is 7.87% down from last year.
  • As of FY2023, Mereo BioPharma Group's Treasury Shares stood at $1.2 million, which was down 7.87% from $1.3 million recorded in FY2022.
  • In the past 5 years, Mereo BioPharma Group's Treasury Shares registered a high of $923,400 during FY2023, and its lowest value of $855,375 during FY2024.
  • For the 2-year period, Mereo BioPharma Group's Treasury Shares averaged around $889,388, with its median value being $889,388 (2023).
  • Data for Mereo BioPharma Group's Treasury Shares shows a maximum YoY declined of 13.13% (in 2022) over the last 5 years.
  • Mereo BioPharma Group's Treasury Shares (Yearly) stood at $1.7 million in 2020, then fell by 8.30% to $1.5 million in 2021, then dropped by 13.13% to $1.3 million in 2022, then declined by 7.87% to $1.2 million in 2023.